Visceral leishmaniasis: Biology of the parasite

Journal of Infection

Volumn 39, Issue 2, 1999, Pages 101-111

  Hommel, Marcel ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT;

HOST PARASITE INTERACTION; LABORATORY DIAGNOSIS; LEISHMANIA; LIFE CYCLE; PARASITE CULTIVATION; PARASITE TRANSMISSION; PARASITE VIRULENCE; REVIEW; TAXONOMY; VACCINATION; VISCERAL LEISHMANIASIS;

EID: 0032697453     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(99)90000-2     Document Type: Article

References (79)

1. Ashford RW, Desjeux P, de Raadt P. Estimation of population at risk and number of cases of leishmaniasis. Parasit Today 1992; 8: 104-105.
2. Badaro R, Jones TC, Lorenco R et al. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Inf Dis 1986; 154: 639-649.
3. Seaman J, Mercer AJ, Sondorp E. The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol 1996; 25: 862-871.
4. Rosenthal E, Marty P, Poizot-Martin I et al. Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans Roy Soc Trop Med Hyg 1995; 89: 159-162.
5. Donovan C. The etiology of the heterogeneous fevers in India. Br Med J 1903; 2: 1401-1403.
6. Magill AJ, Grogl M, Gasser RA et al. Viscerotropic leishmaniasis caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993; 328: 1383-1387.
7. Rioux JA, Lanotte G, Serres E et al. Taxonomy of Leishmania. Use of zymodemes. Suggestions for a new classification. Ann Parasit Hum Comp 1990; 65: 111-125.
8. Schönian G, Schweynoch C, Zlateva K et al. Identification and determination of the relationships of species and strains within the genus Leishmania using single primers in the polymerase chain reaction. Mol Bioch Parasitol 1996; 77: 19-29.
9. McMahon-Pratt D, David JR. Monoclonal antibodies that distinguish between New World species of Leishmania. Nature 1981; 291: 581-583.
10. Pogue GP, Manju Joshi, Lee NS et al. Conservation of low-copy gene loci in Old World leishmanias identifies mechanisms of parasite evolution and diagnostic markers. Mol Bioch Parasit 1996; 81: 22-40.
11. Gradoni L, Gramiccia M. Leishmania infantum tropism: strain genotype or host immune status? Parasitol Today 1994; 10: 264-267.
12. Bates PA. The developmental biology of Leishmania promastigotes. Exp Parasitol 1994; 79: 215-218.
13. Killick-Kendrick R, Molyneux DH, Hommel M et al. Leishmania in Phlebotomid sandflies. V. The nature and significance of infections of the pylorus and ileum by Leishmania of the braziliensis complex. Proc R Soc B 1977; 198: 201-220.
14. Nicolle Ch, Blaizot C. Virulence des cultures de Leishmania infantum. Sensibilité du chacal au virus du kala azar tunisien. Bull Soc Path Exot 1911; 5: 721-723.
15. Jaffe CL, Grimaldi G, McMahon-Pratt D. The cultivation and cloning of Leishmania. In: Morel CM, ed. Genes and Antigens of Parasites. A Laboratory Manual 1984, 47-91. Rio de Janeiro: Fundaçao Oswaldo Cruz.
16. Kerens RL, Brun R, Krassner SM. A simple, monophasic medium for axenic cultivation of hemoflagellates. J Parasitol 1976; 62: 360-365.
17. Hendricks LD, Wright W. Diagnosis of cutaneous leishmaniasis by in vitro cultivation of saline aspirates in Schneider's Drosophila medium. Am J Trop Med Hyg 1979; 28: 962-964.
18. Merlen T, Sereno D, Brajon N et al. Leishmania spp.: completely defined medium without serum and macromolecules (CDM/LP) for the continuous in vitro cultivation of infective promastigote forms. Am J Trop Med Hyg 1999; 60: 41-50.
19. Sacks DL, Hieny S, Sher A. Identification of cell surface carbohydrate and antigenic changes between non-infective and infective developmental stages of Leishmania major promastigotes. J Immunol 1985; 135: 564-569.
20. Zakai HA, Chance ML, Bates PA. In vitro stimulation of metacyclogenesis in Leishmania braziliensis, L. donovani, L. major and L. mexicana. Parasitology 1998; 116: 305-309.
21. Hommel M, Robertson E. Attachment of trypanosomes to plastic. Experientia 1976; 32: 464-465.
22. Lamy LH, Fromentin H, Lamy H. Comparaison, perte et récupération du pouvoir infectieux par les Leishmania en l'absence et en présence de cellules vivantes. Protistologica 1971; 7: 435-437.
23. Alexander J. Effect of the antiphagocytic agent cytochalasin B on macrophage invasion by Leishmania mexicana promastigotes and Trypanosoma cruzi epimastigotes. J Protozool 1975; 22: 237-240.
24. Mattock NM, Peters W. The experimental chemotherapy of leishmaniasis. II. Techniques for the study of drug action in tissue culture. Ann Trop Med Parasit 1975; 69: 349-358.
25. Bates PA. Axenic culture of Leishmania amastigotes. Parasitol Today 1993; 9: 143-146.
26. McMahon-Pratt D, Kima PE, Soong L. Leishmania amastigote target antigens: the challenge of a stealthy intracellular parasite. Parasit Today 1998; 14: 31-34.
27. Chang KP. Cellular and molecular mechanisms by intracellular parasitism in leishmaniasis. Int Rev Cytol, 1983; Suppl 14: 267-305.
28. Mosser DM, Brittingham A. Leishmania, macrophages and complement: a tale of subversion and exploitation. Parasitology 1997; Suppl 115: S9-S23.
29. Kelleher M, Moody SF, Mirabile P, et al. Lipophosphoglycan blocks attachment of Leishmania major to macrophages. Int Immunity, 1995; 63: 43-50.
30. Guy RA, Belosevic M. Comparison of receptors required for entry of Leishmania major amastigotes into macrophages. Inf Immunity 1993; 61: 1553-1558.
31. Zilberstein D. Adaptation of leishmania to an acid environment. In: Coombs GH, North MJ (eds). Biochemical Protozoology 1991, pp. 349-358. London: Taylor and Francis.
32. Dwyer DM, Gottlieb M. Surface membrane localization of 3′- and 5′ nucleosidase activities in Leishmania donovani promastigotes. Mol Bioch Parasit 1984; 10: 139-150.
33. Handman E, Schnur LD, Spithill TW et al. Parasite transfer of Leishmania lipopolysaccharide confers parasite survival in macrophages. J Immunol 1986; 137: 3608-3613.
34. Proudfoot L, Nicolaev AV, Feng GJ et al. Regulation of the expression of nitric oxide synthase and leishmanicidal activity by glycoconjugates of Leishmania lipophosphoglycan in murine macrophages. Proc Natl Acad Sci USA 1996; 93: 10984-10989.
35. Alexander J, Vickerman K. Fusion of host cell secondary lysosomes with the parasitophorous vacuoles of Leishmania rnexicana-infected macrophages. J Protozool 1975; 22: 237-240.
36. Martin I, Turco SJ, Epand RM et al. Lipophosphoglycan of Leishmania donovani inhibits lipid vesicle fusion induced by the N-terminal extremity of viral fusogenic Simian immunodeficiency virus protein. Eur Biochemistry 1998; 258: 150-156.
37. Marchal IS, Marchai T, Moore PF et al. Infection of canine Langerhans cell and interdigitating dendritic cell by Leishmania infantum in spontaneous canine leishmaniasis. Rev Méd Vét 1997; 148: 29-36.
38. Mauel J. Intracellular survival of protozoan parasites with special reference to Leishmania spp., Toxoplasma gondii and Trypanosoma cruzi. Adv Parasit 1996; 38: 1-51.
39. Diefenbach A, Schindler H, Dornhauser N et al. Type 1 interferon (IFN α/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 1998; 8: 77-87.
40. Barral A, Barral Netto M, Yong EC et al. Transforming growth factor-β as a virulence mechanism for Leishmania braziliensis. Proc Natl Acad Sci USA 1993; 90: 3442-3446.
41. Sartori A, Oliveira MA, Scott P et al. Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells. J Immunol 1997; 159: 2849-2857.
42. Moore KJ, Matlashewski G. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J Immunol 1994; 152: 2930-2937.
43. Descoteaux A. Leishmania cysteine proteinases: virulence factors in quest of a function. Parasit Today 1998; 14: 220-221.
44. Russell DG. Biology of the Leishmania surface: with particular reference to the surface proteinase, gp63. Protoplasma 1994; 181: 191-201.
45. Poonam S, Ranju R, Rakeshh B. Differential expression of stress proteins in virulent and attenuated promastigotes of Leishmania donovani. Bioch Mol Biol Intern 1994; 33: 691-697.
46. Bradley DJ, Taylor BA, Blackwell J et al. Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse. Clin Exp Immunol 1979; 37: 7-14.
47. Blackwell JM. Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 1996; 112 (Suppl): S67-S74.
48. Thakur CP. Epidemiological, clinical and therapeutic features of Binar kala azar (including post kala-azar dermal leishmaniasis). Trans R Soc Trop Med Hyg 1984; 78: 391-398.
49. Cabrera M, Shaw MA, Sharples C et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182: 1259-1264.
50. Osman OF, Kager PA, Zijlstra EE et al. Use of PCR on lymph node samples as test of cure of visceral leishmaniasis. Ann Trop Med Parasit 1977; 91: 845-850.
51. Kar K. Serodiagnosis of leishmaniasis. Curr Rev Microbiol, 1995; 21: 123-152.
52. Badaro R, Reed SG, Carvalho EM. Immunofluorescence test in American visceral leishmaniasis: sensitivity and specificity of different morphological forms of two Leishmania species. Am J Trop Med Hyg 1983; 32: 480-484.
53. Hommel M, Peters W, Ranque M et al. The micro-ELISA technique in the serodiagnosis of visceral leishmaniasis. Ann Trop Med Parasit 1978; 72: 213-218.
54. Harith AE, Kolk AH, Kager PA et al. A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis. Trans R Soc Trop Med Hyg 1986; 80: 583-587.
55. Rolland L, Zilberfard V, Furtado A et al. Identification of a 94-kilodalton antigen on Leishmania promastigote forms and its specific recognition in human and canine visceral leishmaniasis. Parasite Immunol 1994; 16: 599-608.
56. Napier LE. A new serum test for kala azar. Ind J Med Res 1922; 9: 830-836.
57. Houghton RE, Petrescu M, Benson DR et al. A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for viseral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug theapy. J Inf Dis 1998; 177: 1339-1344.
58. Zijlstra EE, Daifalla NS, Kager PA et al. rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. Clin Diagn Lab Immunol 1998; 5: 717-720.
59. Badaro R, Benson D, Eulalio MC et al. rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Inf Dis 1996; 173: 758-761.
60. Azazy AA, Chance ML, Devaney E. A time-course study of circulating antigen and parasite-specific amtibody in cotton rats infected with Leishmania donovani. Ann Trop Med Parasit 1997; 91: 153-162.
61. Attar ZE, Chance ME, Dourado C et al. Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis (submitted for publication)
62. Olliaro PE, Bryceson ADM. Practical progress and new drugs for changing patterns of leishmaniasis. Parasit Today 1993; 9: 323-328.
63. Chance ME, Goad EJ. Sterol metabolism of Leishmania and trypanosomes: potential for chemotherapeutic exploitation. In: Hide G, Mottram JC, Coombs GH and Holmes PH (eds.) Trypanosomiasis and leishmaniasis. Biology and Control 1997, pp 163-176. Wallinford: CAB International.
64. Iwu MM, Jackson JE, Schuster BG. Medicinal plants in the fight against leishmaniasis. Parasit Today 1994; 10: 65-68.
65. Davidson RN, Di Martino E, Gradoni L et al. Eiposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial. Quart J Med 1994; 87: 75-81.
66. Sundar S, Rosenkaimer F, Makharia M, et al. Clear-cut efficacy of oral miltefosine in the treatment of visceral leishmaniasis. 2nd European Congress on Tropical Medicine, 1998, Liverpool. P112
67. Sundar S, Rosenkaimer F, Murray HW. Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-γ. J Inf Dis 1994; 170: 659-662.
68. Badaro R, Nascimento C, Carvalho JS et al. Recombinant human granulocyte-macrophage colony stimulating factor reverses netropenia and reduces secondary infections in visceral leishmaniasis. J Inf Dis 1994; 170: 413-418.
69. Moddaber F. Experiences with vaccines against cutaneous leishmaniasis: of men and mice. Parasitology 1989; 98: S49-S60.
70. Sharifi I, Fekri AR, Aflatonian MR et al. Randomized vaccine trial of single dose of killed leishmania antigen plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet 1998; 351: 1540-1543.
71. Antunes CM, Mayrink W, Magalhaes PA et al. Controlled field trials of a vaccine against New World cutaneous leishmaniasis. Int J Epidemiol 1986; 15: 572-580.
72. Handman E. Leishmania vaccines: old and new. Parasit Today 1997; 13: 236-238.
73. Hommel M, Jaffee C, Travi B et al. Experimental models for leishmaniasis and for testing anti-leishmanial vaccines. Ann Trop Med Parasit 1995; 89 (Suppl 1): 55-73.
74. Mayrink W, Genaro O, Silva JC et al. Phase I and II open clinical trials of a vaccine against Leishmania chagasi infections in dogs. Mem Inst Oswaldo Cruz 1996; 91: 695-697.
75. Dye C. The logic of visceral leishmaniasis control. Am J Trop Med Hyg 1996; 55: 125-130.
76. Marzochi MC, Marzochi KB, Carvalho RW. Visceral leishmaniasis in Rio de Janeiro. Parasit Today 1994; 10: 37-40.
77. Ozon C, Marty P, Pratlong F et al. Disseminated feline leishmaniosis due to Leishmania infantum in southern France. Vet Parasit 1998; 75: 273-277.
78. Kubar J, Quaranta JF, Marty P et al. Transmission of L. infantum by blood donors. Nature Medicine 1997; 3: 368.
79. Killick-Kendrick R, Killick-Kendrick M, Focheux C et al. Protection of dogs from bites of phlebotomine sandflies by deltamethrin collars for control of canine leishmaniasis. Med Vet Entomol 1997; 11: 105-111.